Huawei is pushing the boundaries of health technology within the realm of wearables. Earlier this month, a leak suggested that the company’s innovative blood pressure monitoring technology for wearables might debut in September. However, Huawei appears to be delving into other health tech advancements as well.
Recently, Huawei unveiled improvements to its Trusense system, which include enhanced sensing modules, detection algorithms, and big data modeling. But what does this entail for consumers? Essentially, Huawei is developing technology that could diagnose respiratory issues by analyzing the sound of a cough. Here's a brief look at what the future holds for wearables.
Smartwatches May Soon Analyze Your Cough
Huawei highlighted two significant advancements in wearable health technology. First, the company is pioneering research in respiratory health. The Chinese tech leader has gathered samples of various cough sounds and physiological metrics like respiratory rate and heart rate. These inputs are processed through their algorithm to identify potential lung infection risks. The system can also conduct screenings for chronic obstructive pulmonary disease and assess lung function. This capability is powered by Huawei’s Trusense technology on wearables, which can listen to coughs. The company assures the accuracy of respiratory health monitoring through its software and hardware innovations.
New Vascular Health & Risk Screening Technology
In addition to respiratory health innovations, Huawei is also focused on bridging the gap in cardiovascular health. It is developing advanced sensors alongside enhanced software to detect crucial vascular health indicators. By integrating state-of-the-art hardware and software, Huawei aims to identify cardiovascular risks users may encounter.
What is the Huawei TruSense System?
In essence, Huawei is redefining wearable health technology. This is evident through advancements in sensing modules, refined detection algorithms, and big data models for superior health monitoring. TruSense has expanded its exploration into areas such as coronary heart disease, mental health, blood pressure, and blood glucose monitoring.
Collaborations with Industry Experts
Huawei Wearables and the Huawei TruSense system are actively collaborating with the EU’s leading cardiovascular research initiative, iCARE4CVD. This partnership includes top industry academics and institutions and involves a total investment exceeding 20 million Euros over five years. Huawei is spearheading patient management discussions and is the exclusive wearable device manufacturer participating in the initiative.
